• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017

tetano

Editor, Senior Moderator
PLoS One


. 2022 Sep 23;17(9):e0271321.
doi: 10.1371/journal.pone.0271321. eCollection 2022.
Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017


Alhassan Mohammed Yakubu[SUP] 1 2 [/SUP], Nii Ayite Aryee[SUP] 1 [/SUP], Evelyn Yayra Bonney[SUP] 3 [/SUP], Erasmus Nikoi Kotey[SUP] 3 4 5 [/SUP], Joseph Humphrey Kofi Bonney[SUP] 3 5 [/SUP], Michael R Wiley[SUP] 6 [/SUP], Catherine B Pratt[SUP] 6 [/SUP], Grace Korkor Ababio[SUP] 1 [/SUP], Shieley Nimo-Paintsil[SUP] 5 [/SUP], Naiki Puplampu[SUP] 5 [/SUP], Seth Attoh[SUP] 7 [/SUP], Raymond D Fatchu[SUP] 7 [/SUP], Edward Owusu Nyarko[SUP] 2 [/SUP], Anne Fox[SUP] 5 [/SUP], Chaselynn M Watters[SUP] 5 [/SUP], Terrel Sanders[SUP] 5 [/SUP], Andrew G Letizia[SUP] 8 [/SUP], William Kwabena Ampofo[SUP] 3 [/SUP]



Affiliations

Abstract

Recent reports of haemagglutinin antigen (HA) mismatch between vaccine composition strains and circulating strains, have led to renewed interest in influenza B viruses. Additionally, there are concerns about resistance to neuraminidase inhibitors in new influenza B isolates. To assess the potential impact in Ghana, we characterized the lineages of influenza B viruses that circulated in Ghana between 2016 and 2017 from different regions of the country: Southern, Northern and Central Ghana. Eight representative specimens from the three regions that were positive for influenza B virus by real-time RT-PCR were sequenced and compared to reference genomes from each lineage. A total of eleven amino acids substitutions were detected in the B/Victoria lineage and six in the B/Yamagata lineage. The strains of influenza B viruses were closely related to influenza B/Brisbane/60/2008 and influenza B/Phuket/3073/2013 for the Victoria and Yamagata lineages, respectively. Three main amino acid substitutions (P31S, I117V and R151K) were found in B/Victoria lineages circulating between 2016 and 2017, while one strain of B/Victoria possessed a unique glycosylation site at amino acid position 51 in the HA2 subunit. Two main substitutions (L172Q and M251V) were detected in the HA gene of the B/Yamagata lineage. The U.S. CDC recently reported a deletion sub-group in influenza B virus, but this was not identified among the Ghanaian specimens. Close monitoring of the patterns of influenza B evolution is necessary for the efficient selection of representative viruses for the design and formulation of effective influenza vaccines.
 
Back
Top Bottom